CPC C07J 9/005 (2013.01) [A61P 31/04 (2018.01)] | 17 Claims |
1. A cationic steroidal antimicrobial (CSA) compound having a structure of Formula II, or a salt thereof:
where,
rings A, B, C, and D are saturated; and
R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R16, R17, and R18 are independently selected from the group consisting of hydrogen, hydroxyl, alkyl, hydroxyalkyl, alkyloxyalkyl, alkylcarboxyalkyl, alkylaminoalkyl, alkylaminoalkylamino, alkylaminoalkylaminoalkylamino, aminoalkyl, aryl, arylaminoalkyl, haloalkyl, alkenyl, alkynyl, oxo, linking group attached to a second steroid, aminoalkylurethanyl, aminoalkenylurethanyl, aminoalkynylurethanyl, aminoarylurethanyl, aminoalkyloxy, aminoalkylcarboxy, aminoalkyloxyalkyl, aminoalkylaminocarbonyl, aminoalkylcarboxamido, di(alkyl)aminoalkyl, H2N—HC(Q5)-(C═O)—O—, H2N—HC(Q5)-(C═O)—NH—, azidoalkyloxy, cyanoalkyloxy, P.G.-HN—HC(Q5)-(C═O)—O—, guanidino-alkyloxy, quaternary ammonium alkylcarboxy, and guanidinoalkyl carboxy, where Q5 is a side chain of an amino acid and P.G. is an amino protecting group,
provided that at least three of R1, R2, R3, R4, R6, R7, R11, R12, R16, and R18 are independently selected from the group consisting of aminoalkylurethanyl, aminoalkenylurethanyl, aminoalkynylurethanyl, and aminoarylurethanyl.
|